Brief: Gentian Diagnostics Sales Up At NOK 32.7 Mln
Oct 31 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* SALES OF NOK 32.7 MILLION IN 3Q24, UP 2% VERSUS 3Q23 (5%
ORGANIC
GROWTH)
* EBITDA OF NOK 5.0 MILLION IN 3Q24 VERSUS NOK 1.2 MILLION
IN 3Q23
* CASH POSITION OF NOK 93.8 MILLION AT END OF QUARTER
COMPARED TO
NOK 76.4 MILLION AT END OF 3Q23
Source text: ID:nObidXdbqa
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company